Glat Neil sold (to issuer) 32,591 shares of EVLV

Glat Neil sold (to issuer) 32,591 shares of Evolv Technologies Holdings, Inc. (EVLV) across 2 trades on 2026-07-16.

Original reporting
SEC EDGAR · Glat Neil
Published Oct 6, 2026, 8:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 8:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EVLV
Bearish
medium confidence
Mentioned
$EVLV
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EVLVBearishLow
01

Why it matters

The director's sale may be interpreted as a slight bearish cue, but the overall impact is limited given the modest size and lack of price information.

02

Market read

Provides a fresh insider transaction that could influence short‑term sentiment for EVLV.

03

What to watch

The director retains a sizable holding of 219,509 shares, indicating continued confidence.

Relevance 5/10Novelty 5/10Timing: post‑filing today

Background

SEC Form 4 filings disclose insider transactions and are primary sources for such events.

Company-level read

Ticker impact

$EVLVBearishMedium confidence
Context

Director Glat Neil sold 32,591 shares of Evolv Technologies Holdings (EVLV) in a Form 4 filing.

Expected impact

likely modest pressure as the market prices in the insider sell

Evidence & confidence

A director disposing of ~32k shares represents a non‑trivial stake reduction, but the amount is modest relative to total float and no price was disclosed.

Market effects

Minimal impact on the broader technology sector; the filing is company‑specific.

No significant regional effect.

Limited to investors tracking EVLV.

Counterpoint

The sale could be a routine portfolio rebalancing rather than a negative signal.

Key entities

  • Evolv Technologies Holdings, Inc.

    Issuer of the shares sold.

  • Glat Neil

    Director of EVLV who sold the shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RKLBMed

Selling Some Rocket Lab After Launch Record

Rocket Lab (RKLB) achieved its 100th Electron launch, deploying a satellite for iQPS. Goldman Sachs raised its target price to $68. ULA's Vulcan rocket failed, destroying Amazon's (AMZN) satellites, halting launches. Analysts adjusted targets for Ondas Inc (ONDS). Peloton (PTON) launched a cheaper treadmill, the Tread Flex, aiming to boost affordability.

$EVLVMed

Evolv Technology Reports Third Quarter Financial Results

Evolv Technologies Holdings, Inc. (EVLV) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Evolv Technology Reports Third Quarter Financial Results • Q3'26 Revenue of $47.3 million, up 10% year-over-year • Q3'26 Ending ARR 1 of $140.5 million, up 20% year-over-year • Q3'26 Net Loss of $(15.6) million, with Net Profit Margin of (32.9)% • Q3'26 Adjusted EBIT

$EVLVMed

Evolv Technologies Holdings, Inc. Q2 2026 Earnings Call Summary

Evolv Technologies Holdings reported 34% Q2 2026 revenue growth, citing new customer acquisition and completion of a direct fulfillment transition. Management raised full-year 2026 revenue guidance to 23% to 27% growth, expects over 10,000 units deployed by year-end, and remains cash-flow positive while potentially investing $2m to $4m in inventory safety stock.

$EVLVHigh

Evolv Technology Reports Second Quarter Financial Results

Evolv Technologies Holdings, Inc. (EVLV) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Evolv Technology Reports Second Quarter Financial Results — Company Adds 70 New Customers — — Company Raises Growth Estimates for 2026 — • Q2'26 Revenue of $43.8 million, up 34% year-over-year • Q2'26 Ending ARR 1 of $132.7 million, up 20% year-over-year • Q2'26 Net